New York, NY -- (SBWIRE) -- 12/31/2018 -- Qyresearchreports include new market research report Liposome Drug Delivery to its huge collection of research reports.
This report studies the global Liposome Drug Delivery (Liposomes Drug Delivery) market status and forecast, categorizes the global Liposome Drug Delivery (Liposomes Drug Delivery) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
Save UP TO 15% On All Reports: https://www.qyresearchreports.com/year-end-offer
In consideration of the global economic and pharma industry, the growth rate of Liposomes Drug Delivery market will keep high in the next several years. The revenue market size expected to be 3.6 billion USD in 2020 at a CAGR of 8.57%.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
Liposomes have been used in a broad range of pharmaceutical applications. Liposomes are showing particular promise as intracellular delivery systems for anti-sense molecules, ribosomes, proteins/peptides, and DNA. Liposomes with enhanced drug delivery to disease locations, by ability of long circulation residence times, are now achieving clinical acceptance. Also, liposomes promote targeting of particular diseased cells within the disease site.
Finally, liposomal drugs exhibit reduced toxicities and retain enhanced efficacy compared with free complements. Based on the pharmaceutical applications and available products, we can say that liposomes have definitely established their position in modern delivery systems.
For more info, get sample report for FREE here: https://www.qyresearchreports.com/sample/sample.php?rep_id=1846157&type=S
The global Liposome Drug Delivery (Liposomes Drug Delivery) market is valued at 2400 million US$ in 2017 and will reach 5190 million US$ by the end of 2025, growing at a CAGR of 10.1% during 2018-2025.
The major manufacturers covered in this report
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
The study objectives of this report are:
To analyze and study the global Liposome Drug Delivery (Liposomes Drug Delivery) sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Liposome Drug Delivery (Liposomes Drug Delivery) manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Browse Complete Research Report at: https://www.qyresearchreports.com/report/global-liposome-drug-delivery-liposomes-drug-delivery-market-research-report-2018.htm
Table of Contents
1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Overview
1.1 Product Overview and Scope of Liposome Drug Delivery (Liposomes Drug Delivery)
1.2 Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Type (Product Category)
1.2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Type (Product Category) in 2017
1.2.3 Liposomal Doxorubicin
1.2.4 Liposomal Amphoteracin B
1.2.5 Liposomal Paclitaxel
1.2.6 Other
1.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Segment by Application
1.3.1 Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Market Competition by Manufacturers
2.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and Share by Manufacturers (2013-2018)
2.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue and Share by Manufacturers (2013-2018)
2.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Liposome Drug Delivery (Liposomes Drug Delivery) Manufacturing Base Distribution, Sales Area and Product Type
2.5 Liposome Drug Delivery (Liposomes Drug Delivery) Market Competitive Situation and Trends
2.5.1 Liposome Drug Delivery (Liposomes Drug Delivery) Market Concentration Rate
2.5.2 Liposome Drug Delivery (Liposomes Drug Delivery) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity and Market Share by Region (2013-2018)
3.2 Global Liposome Drug Delivery (Liposomes Drug Delivery) Production and Market Share by Region (2013-2018)
3.3 Global Liposome Drug Delivery (Liposomes Drug Delivery) Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Liposome Drug Delivery (Liposomes Drug Delivery) Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
...
List of Tables and Figures
Figure Picture of Liposome Drug Delivery (Liposomes Drug Delivery)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Liposomal Doxorubicin
Table Major Manufacturers of Liposomal Doxorubicin
Figure Product Picture of Liposomal Amphoteracin B
Table Major Manufacturers of Liposomal Amphoteracin B
Figure Product Picture of Liposomal Paclitaxel
Table Major Manufacturers of Liposomal Paclitaxel
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption (K Units) by Applications (2013-2025)
Figure Global Liposome Drug Delivery (Liposomes Drug Delivery) Consumption Market Share by Applications in 2017
Figure Fungal Infection Therapy Examples
Table Key Downstream Customer in Fungal Infection Therapy
Figure Cancer & Tumor Therapy Examples
Table Key Downstream Customer in Cancer & Tumor Therapy
...
About QYResearchReports
QYResearchReports delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com